The 2019 Coronavirus Disease (COVID-19) has caused substantial morbidity and mortality throughout the world. COVID-19 outcomes in transplant patients can be influenced by pre-immunosuppression as well as other co-morbidities. This was a single-center prospective cohort research of kidney transplant recipients (KTRs) who received a kidney transplant between December 2012 and November 2020, were followed up at our center, and were diagnosed with COVID-19 disease between April 1 and November 30, 2020. Due to their immunosuppression, patients who have had a kidney transplant are at a significant risk of contracting COVID-19. Initial symptoms in COVID-19-positive KTRs are comparable to those seen in the general population. In comparison to the general population, KTRs have a greater mortality rate
